Results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca’s (AZN) camizestrant in combination with a ...
Positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca’s (AZN) camizestrant in ...
Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in ...
In the Phase III SERENA-6 trial, camizestrant—in combination with CDK-inhibitors—beat out current standard-of-care treatments ...
52m
Complex I Music, Sneakers, Pop Culture, News on MSNSerena Williams Is the Newest Member of WNBA's Toronto Tempo Ownership GroupSerena Williams is making a foray into a new sport. On Monday, Williams announced she's joining the WNBA Toronto Tempo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results